Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Analyst Coverage

Analyst Coverage

Firm Analyst
Cowen
    Boris Peaker
    H.C. Wainwright
      Yi Chen
      Ladenburg Thalmann Securities
        Matthew Kaplan
        OPN Capital Markets
          Jonathan Aschoff
          Wedbush Securities, Inc.
            David Nierengarten

            Stemline Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Stemline Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Stemline Therapeutics or its management. Stemline Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.



            Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved